Another gene, SLC4A4, was found to be significantly correlated with shorter survival of CRC patients and a marker of poorer progression for patients with breast cancer, lung cancer, gastric cancer, and ovarian cancer. This evidence concerns the gene SLC4A4 and ovarian carcinoma.